✦ LIBER ✦

Clinical use of tacrolimus (FK-506) in infants and children with renal transplants

✍ Scribed by Demetrius Ellis

Publisher: Springer
Year: 1995
Tongue: English
Weight: 1009 KB
Volume: 9
Category: Article
ISSN: 0931-041X
DOI: 10.1007/bf00866738

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved renal allograft survival in chi

Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy

✍ Howard E. Corey; Vivian Tellis; Richard Schechner; Stuart M. Greenstein 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 74 KB

Diabetes as a complication of tacrolimus

Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients

✍ Susan Furth; Alicia Neu; Paul Colombani; Leslie Plotnick; Mary Ellen Turner; Bar 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 370 KB

Comparison of FK-506 and cyclosporine re

Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation

✍ Demetrius Ellis; Ron Shapiro; Mark L. Jordan; Velma P. Scantlebury; Nisan Gilboa 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 967 KB

A comparative study of FK506 granules an

A comparative study of FK506 granules and capsules in renal transplant recipients

✍ S. Takahara; Tsuneharu Miki; Motoaki Hatori; Yukito Kokado; Jingding Wang; Akihi 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 176 KB

Pronounced renal vasoconstriction and sy

Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506

✍ J. Radermacher; Martina Meiners; Cornelia Bramlage; Volker Kliem; Matthias Behre 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 293 KB

Occurrence of gammopathies and lymphopro

Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression

✍ Pham, Hung ;Lemoine, Antoinette ;Salvucci, Marina ;Azoulay, Daniel ;Frenoy, Nico 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB

Lymphoproliferative disorders (LPDs) are a serious side effect of immunosuppression after liver transplantation, and the introduction on the market of a new immunosuppressive drug has been associated with an increased risk of these disorders. To compare the effect of cyclosporine A (CSA) and FK506 i